Cidara Therapeutics, Inc.
CDTX
Classement en actions
#3182
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Prix de l'action
$221.38
Dernière synchronisation: 2026-01-08
Capitalisation boursière
$5.61B
Changement (1 jour)
0.00%
Changement (1 an)
120.15%
Pays
US
Échange Cidara Therapeutics, Inc. (CDTX)
Catégorie
Healthcare
Nombre d'actions en circulation pour Cidara Therapeutics, Inc. (CDTX)
Nombre d'actions en circulation au September 2025: 15.55M
Selon les derniers rapports financiers et le cours de l'action de Cidara Therapeutics, Inc., le nombre actuel d'actions en circulation est de 15.55M. À la fin de December 2023, l'entreprise avait 4.37M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Cidara Therapeutics, Inc. (CDTX) de 2012 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 15.55M | 144.86% |
| 2024 | 6.35M | 45.25% |
| 2023 | 4.37M | 25.15% |
| 2022 | 3.49M | 33.24% |
| 2021 | 2.62M | 26.16% |
| 2020 | 2.08M | 38.83% |
| 2019 | 1.50M | 15.71% |
| 2018 | 1.29M | 47.82% |
| 2017 | 875.04K | 20.79% |
| 2016 | 724.45K | 5.22% |
| 2015 | 688.48K | 1,579.52% |
| 2014 | 40.99K | 153.29% |
| 2013 | 16.18K | -8.65% |
| 2012 | 17.72K | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 1,533.07% |
US
|
|
| 396.00M | 2,447.05% |
US
|
|
| 478.91M | 2,980.33% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | 299.97% |
NL
|
